BLOOD AND BONES - ANZONA Conference · 2019-10-28 · recommendation(s ) But care should be taken...
Transcript of BLOOD AND BONES - ANZONA Conference · 2019-10-28 · recommendation(s ) But care should be taken...
BLOOD AND BONES
Angie Monk Patient Blood Management Clinical Nurse Consultant Joondalup Health Campus
ANZONA27th October 2017
London
Blood and blood products Standard 7
Hong Kong
Blood and blood products Standard 7
Australia
Blood and blood products Standard 7
Australian Nurse of the year 2016
Blood and blood products Standard 7
Why PBM
• Preoperative anaemia has been shown to be associated with an increased risk of adverse outcomes
• Patients with preoperative anaemia are more than three times likely to have received transfusions than in those who did not.
Blood and blood products Standard 7
WA leads the way in PBM
• In 2009 a PBM program was introduced into Fremantle hospital and was successful in significantly dropping the transfusion rate.
• 2011-2015 WA DOH funded PBM CNCs to develop and implement PBM programs in four main adult tertiary metropolitan hospitals with the support of a team including Trudi Gallagher WA PBM nurse co-ordinator.
• 2015 – Funding for PBM CNC was handed over individual tertiary hospitals
• 2017 - A PBM WA study of the 604,046 public patients undertaken by Professor Michael Leahy and showed :
28% reduction in hospital mortality15% reduction in average hospital length of stay21% decrease in hospital-acquired infections31% decrease in the incidence of heart attack or stroke.
My PBM Story
• 2011-Introduced PBM at JHC with support of WA PBM team .• 2012-Introduced thromboelestometry (ROTEM )• 2014 –Improved patient outcome measured by:
- THR transfusion rate dropped from 39- 8- TKR transfusion rate dropped from 17- 4
• 2015-2017The Australian Commission on Safety and Quality in Health Care led the National Patient Blood Management Collaborative to support improvements in the management of anaemia and iron deficiency for patients having elective gastrointestinal, gynaecological and orthopaedic surgical procedures. JHC was one of 12 hospitals selected to participate.
Blood and blood products Standard 7
GRADE A Body of evidence can be trusted to guide practice
GRADE B Body of evidence can be trusted to guide practice in most situations
GRADE C Body of evidence provides some support for recommendation(s )But care should be taken in its application.
GRADED Body of evidence is weak and recommendations must be applied with caution
Engaging Clinicians in three pillars of PBM
Clinical engagement
Blood and blood products Standard 7
Resource developmentfor use in anaemia clinic
– iron infusion prescribing chart which includes consent – preoperative anaemia pathway– Iron infusion patient leaflet with consumer input outlining
the procedure and necessary precautions.– Letters drafted and factsheets designed for provision to
patient and GPs outlining requirements for pre-operative anaemia assessment
Blood and blood products Standard 7
Change Management Evidence based practice
Blood and blood products Standard 7
Engaging primary health care teamGP anaemia workshop
Blood and blood products Standard 7
Referral process
• Patients requiring joint replacement are referred to orthopaedic surgeon .
• urgent conditions are scheduled to be seen within 30 days.
• Routine conditions are given the next available appointment according to clinical need.
Blood and blood products Standard 7
Practice engagement
Blood and blood products Standard 7
Pre-operative screening
Blood and blood products Standard 7
• All patient undergoing surgery where large blood loss can be anticipated, should be screened and managed preoperatively for iron deficiency/iron deficiency anaemia.
• Untreated anaemia, even to a small extent, increases the risk of complications and mortality in the context of surgery
Three Pillars OF PBM
Pillar 1 Pillar 2 Pillar 3
Anaemia management to optimise red cell
mass
Minimise blood loss Optimise tolerance of anaemia
• Detect & treat anaemia
• Time Sx with RBC mass optimisation
• Identify and Rx bleeding/bleeding risk
• Meticulous anaesthetic/surgical techniques
• Positioning/warming
• Minimise phlebotomy
• Only Tx when required
• Restrictive Tx practice: single unit guideline
Pillar 1: Optimise red cell mass
Blood and blood products Standard 7
GP
Consulting Rooms
SMAC
Referred to PBM CNC
Booked for IV iron infusion
telephone consult with patient re-management plan
or send a letter to patient.
PBM letter to GP.
Meet with Clinical director of PBM –management plan
JHC Pre-Operative screening process
Blood and blood products Standard 7
Management plan – IV iron
Blood and blood products Standard 7
ANAEMIA TRENDS
Blood and blood products Standard 7
207 178 154271 246
4
25092
345158
277
557431 454
8911042
611
443
84
419
704
746359
189 200
418
394
338
482
128
368
69
162
264
0
200
400
600
800
1000
1200
1400
1600
1800
HS1 HS2 HS3 HS4 HS5 HS6 HS7 HS8 HS9 HS10 HS11 HS12
Gastrointestinal(2182) Orthopaedic(6741) Gynaecology(3012)
Total procedures by surgical stream by health serviceas at end of February 2017
This total includes a small number of procedures which predate May 2015
Total 11 935
Percentage of patients receiving pre-operative assessment for anaemia per month – May 2015 to February 2017
60%
65%
70%
75%
80%
85%
90%
95%
100%
May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
Percentage of patients confirmed with anaemia per month – May 2015 to February 2017
0%
2%
4%
6%
8%
10%
12%
14%
16%
18%
20%
May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
Percentage of patients with anaemia managed per month – May 2015 to February 2017
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
IRON DEFICIENCY TRENDS
Blood and blood products Standard 7
Percentage of patients receiving pre-operative assessment for iron deficiency per month – May 2015 to February 2017
0%
10%
20%
30%
40%
50%
60%
70%
80%
May Jul Sep Nov Jan Mar May Jul Sep Nov Jan
Percentage of patients confirmed with iron deficiency per month – May 2015 to February 2017
0%
5%
10%
15%
20%
25%
30%
35%
May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
Percentage of patients with iron deficiency managed per month – May 2015 to February 2017
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
SURGICAL STREAMS
Blood and blood products Standard 7
Percentage of patients who were confirmed with iron deficiency by surgical stream by quarter
42%
49%
14%
51%48%
19%
52%
39%
19%
43%46%
17%
37%
41%
16%
42%
37%
17%
0%
10%
20%
30%
40%
50%
60%
Gynaecological Gastrointestinal Orthopaedic
Q1Jul-Sep15 Q2Oct-Dec15 Q3Jan-Mar16 Q4Apr-Jun16 Q5Jul-Sep16 Q6Oct-Dec16
Percentage of patients with iron deficiency who were managed by surgical stream by quarter
48%51%
56%
47%
59%64%
50%
58% 59%57%
75%
54%
70%66%
56%
71%68% 68%
0%
10%
20%
30%
40%
50%
60%
70%
80%
Gynaecological Gastrointestinal Orthopaedic
Q1Jul-Sep15 Q2Oct-Dec15 Q3Jan-Mar16 Q4Apr-Jun16 Q5Jul-Sep16 Q6Oct-Dec16
Percentage of patients with both anaemia and iron deficiency who were managed by surgical stream by quarter
54% 52%
33%
71%
53%
85%86%
54%60%
50%
81%
50%
90%
73%
38%
71%67%
70%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Gynaecological Gastrointestinal Orthopaedic
Q1Jul-Sep15 Q2Oct-Dec15 Q3Jan-Mar16 Q4Apr-Jun16 Q5Jul-Sep16 Q6Oct-Dec16
Number of patients who received transfusions, by month
– May 2015 to February 2017
NB: Further data will be entered for these months
0
10
20
30
40
50
60
May-15
Jun-15
Jul-1
5
Aug-15
Sep-15
Oct-15
Nov-15
Dec-15
Jan-16
Feb-16
Mar-16
Apr-16
May-16
Jun-16
Jul-1
6
Aug-16
Sep-16
Oct-16
Nov-16
Dec-16
Jan-17
Feb-17
Num
bero
fpatients
Ante-natal Parental iron Infusion rate 2015-2017
Maternal Anaemia –evidence of association with adverse outcome in pregnancy. Including low birth weight and preterm birth, placental abruption, maternal mortality
and postnatal depression.( ref : NBA Patient Blood Management maternity guidelines 2016).
0
5
10
15
20
25
30
1 2 3 4 5 6 7 8 9 10 11 12
2015
2016
2017
0
10
20
30
40
50
60
1 2 3 4 5 6 7
Transfusion rate in obstetrics 2011- Aug 2017
PBM IN OBSTETRICS
Blood and blood products Standard 7
Pillar 2: Minimise blood loss
How do we minimise blood loss?
Blood and blood products Standard 7
Anaesthetic measures
• Pre op assessment• Type of anaesthetic • Drugs • Induced hypotension • Normothermia • Patient positioning• Acute normovolaemic
haemodilution (ANH)• Guidelines for massive
blood loss
Blood and blood products Standard 7
Surgical Measures
• Prompt surgical Haemostasis
• Cell salvage• Tourniquet• Topical agents
Blood and blood products Standard 7
Rotational Thromboelastometry(ROTEM)
Real time information about cause of bleeding
Targeted approach for management of bleeding • Surgical problem• Blood products• Drugs (TXA)
Blood and blood products Standard 7
ROTEM Algorithm
Blood and blood products Standard 7
Critical Bleeding Protocol (record)
Blood and blood products Standard 7
Pillar 3: Optimise tolerance to anaemia
Appropriate Transfusion practice
Blood and blood products Standard 7
Post-operative blood salvage
Blood and blood products Standard 7
Blood sampling
• Over sampling ‘routine’• Small volume sample tubes• Point of care testing • Return dead space blood loss
Avoiding iatrogenic anaemia
Blood and blood products Standard 7
Facts about blood
Blood and blood products Standard 7
Transfusion versus IV Iron
Transfusion Indication• Bleeding• Bone marrow failure• Symptomatic anaemia• Iron content: ~ 100mg variable
depends on donor
Iron Indication• Iron deficiency• Replete iron stores when
significant blood loss• Predictable amount of iron• Usual adult dose 500-2000mg
Severe reactions: Transfusion 1:20,000 unitsIV iron 1: 200,000 infusions
Blood and blood products Standard 7
Decision to transfuse
• Transfusions are independently associated with increased risk of morbidity and mortality.
• The decision to transfuse must be based on evidence best practice (PBM guidelines)based on a thorough clinical assessment, where the benefits of transfusion out weigh the potential risk.
Blood and blood products Standard 7
Single unit policy
TRANSFUSION PLAN
Blood and blood products Standard 7
Collecting blood products
Collection of blood products from hospital blood bank
Blood and blood products Standard 7
The transfusion of blood products must begin as soon as possible after delivery to the ward or operating theatre.If this is not possible it must be returned to the blood bank within 30 minutes .Prior to collection of blood ensure ;
• Prescription for blood and consent is completed • IV in situ and patent.• Circumstances/situation appropriate and Staff are available .
Blood and blood products Standard 7
Two staff must perform bedside check one must be the person hanging the blood.
Ensure right patient -right blood
Blood and blood products Standard 7
Thankyou